What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?

1 Young RC. Chemotherapy. In: Berek JS, Hacker NF, eds.Practical Gynecologic Oncology. Baltimore: Williams and Wilkins, 1994: 3-34.

Lund B, 1990, Gynecol Oncol, 7, 279, 10.1016/0090-8258(90)90348-O

Miller DS, 1986, Cancer, 7, 530, 10.1002/1097-0142(19860201)57:3<530::AID-CNCR2820570321>3.0.CO;2-5

Wangensteen OH, 1951, Lancet, 7, 303

Santaro BT, 1961, Surgery, 7, 354

Bast RC, 1981, J Clin Invest, 7, 1331, 10.1172/JCI110380

10.1006/gyno.1993.1075

Mogensen O, 1992, Gynecol Oncol, 7, 207, 10.1016/0090-8258(92)90043-I

Van der Burg ME, 1988, Gynecol Oncol, 7, 307, 10.1016/0090-8258(88)90244-2

Hawkins RE, 1989, Br J Obstet Gynaecol, 7, 1395, 10.1111/j.1471-0528.1989.tb06301.x

Lavin PT, 1987, Obstet Gynecol, 7, 223

10.1006/gyno.1994.1135

Rubin SC, 1989, Am J Obstet Gynecol, 7, 667, 10.1016/S0002-9378(89)80054-7

Patsner B, 1990, Gynecol Oncol, 7, 375

Rome RM, 1987, Aust N Z J Obstet Gynecol, 7, 142, 10.1111/j.1479-828X.1987.tb00966.x

Potter ME, 1989, Gynecol Oncol, 7, 201, 10.1016/0090-8258(89)90552-0

Mogensen O, 1988, Eur J Cancer, 7, 183

Makar AP, 1992, Gynecol Oncol, 7, 323, 10.1016/0090-8258(92)90313-8

Niloff JM, 1985, Am J Obstet Gynecol, 7, 981, 10.1016/0002-9378(85)90678-7

Berek JS, 1986, Obstet Gynecol, 7, 685, 10.1097/00006250-198605000-00016

Gallion HH, 1992, Gynecol Oncol, 7, 29, 10.1016/0090-8258(92)90190-T

10.1006/gyno.1994.1134

10.1006/gyno.1993.1076

10.1016/S0140-6736(88)90640-X